Evidence map›Paper›PMID 38497171›Full record

ArticleHaematologica2024

Stroke without cerebral arteriopathy in sickle cell disease children: causes and treatment.

Sarah Liane Linguet, Suzanne Verlhac, Florence Missud, Laurent Holvoet-Vermaut, Valentine Brousse, Ghislaine Ithier, Alexandra Ntorkou, Emmanuelle Lesprit, Malika Benkerrou, Manoëlle Kossorotoff and 1 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Sarah Liane LinguetReferral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris.
Suzanne VerlhacINSERM UMR_S1134 BIGR, Paris.
Florence MissudReferral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris.
Laurent Holvoet-VermautReferral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris.
Valentine BrousseReferral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris, France; INSERM UMR_S1134 BIGR, Paris.
Ghislaine IthierReferral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris.
Alexandra NtorkouRadiology Unit, Robert Debre Hospital, AP-HP, Paris.
Emmanuelle LespritEtablissement Français du Sang.
Malika BenkerrouReferral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris, France; INSERM UMR_S1123 ECEVE, Paris.
Manoëlle KossorotoffFrench Center for Pediatric Stroke, Pediatric Neurology Department, University Hospital Necker-Enfants Malades, AP-HP, Paris, France; and INSERM U1266, Paris.
Berengere KoehlReferral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris, France; INSERM UMR_S1134 BIGR, Paris, France; Université de Paris Cité, Paris. berengere.koehl@aphp.fr.
Assistance Publique – Hôpitaux de Paris · FRHôpital Robert-Debré · FRInserm · FRÉtablissement Français du Sang · FRSorbonne Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral arteriopathy (CA) in children with sickle cell disease (SCD) is classically described as chronic stenosis of arteries in the anterior brain circulation, leading to ischemic stroke. Some studies have, however, reported strokes in children with SCD but without CA. In order to better understand the etiology and risk factors of these strokes, we retrospectively analyzed ischemic strokes occurring in a large cohort of children over a 13-year period. Between 2007 and 2020, 25 of 1,500 children with SCD had an ischemic stroke in our center. Among them, 13 (52%) had CA, described as anatomical arterial stenosis, while 12 (48%) did not. Patients with stroke without CA were older than patients with stroke attributed to SCD-CA (9.0 years old vs. 3.6 years old; P=0.008), and more frequently had SC genotype (25% vs. 0%, respectively). Their strokes more frequently involved the posterior circulation, with cerebellar involvement in 42%. Retained stroke etiologies in patients without typical SCD-related CA were reversible cerebral vasoconstriction syndrome, cerebral fat embolism, arterial thrombosis or thromboembolism, hyperviscosity, vasculitis in a context of infectious meningo-encephalitis, and severe hemodynamic failure. No recurrence was observed in the 24 months following stroke, even though 67% of the patients in this group were no longer receiving exchange transfusions. In conclusion, in a cohort of pediatric SCD patients with an efficient stroke screening strategy, half of the ischemic strokes that occurred were related to causes other than CA. They affected a different population of SCD children and systematic long-term transfusion programs may not be necessary in these cases.

Indexed as

Anemia, Sickle CellStrokeAdolescentCerebral Arterial DiseasesChildChild, PreschoolFemaleHumansInfantMaleRetrospective StudiesRisk Factors

Identifiers

PMID38497171
PMCPMC11443367
OpenAlexW4392817080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.